Showing 4 of 4 recruiting trials for “triple-a-syndrome”
A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT05984394 ↗
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
RecruitingNCT05989399 ↗
Evaluation of Circulating Neutrophils in Antisynthetase Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →